Pages that link to "Q35531415"
Jump to navigation
Jump to search
The following pages link to TRIM5α does not affect simian immunodeficiency virus SIV(mac251) replication in vaccinated or unvaccinated Indian rhesus macaques following intrarectal challenge exposure (Q35531415):
Displaying 32 items.
- TRIM5α and Species Tropism of HIV/SIV (Q24304062) (← links)
- Impact of TRIM5α in vivo (Q26786870) (← links)
- Review of basic science advances in HIV (Q26849742) (← links)
- Nonhuman primate models for HIV/AIDS vaccine development (Q26861148) (← links)
- Using nonhuman primates to model HIV transmission (Q26861425) (← links)
- Vaccine-Elicited Mucosal and Systemic Antibody Responses Are Associated with Reduced Simian Immunodeficiency Viremia in Infant Rhesus Macaques (Q28830298) (← links)
- Animal models for HIV/AIDS research (Q30423656) (← links)
- Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trial (Q30532861) (← links)
- Immunologic and Virologic Mechanisms for Partial Protection from Intravenous Challenge by an Integration-Defective SIV Vaccine (Q32183405) (← links)
- Immunopathogenesis of simian immunodeficiency virus infection in nonhuman primates (Q33355730) (← links)
- New directions for HIV vaccine development from animal models (Q33767191) (← links)
- Molecularly tagged simian immunodeficiency virus SIVmac239 synthetic swarm for tracking independent infection events (Q33900353) (← links)
- TRIM5α restriction affects clinical outcome and disease progression in simian immunodeficiency virus-infected rhesus macaques (Q35115622) (← links)
- Simple mathematical models do not accurately predict early SIV dynamics (Q35232811) (← links)
- Replicating adenovirus-simian immunodeficiency virus (SIV) recombinant priming and envelope protein boosting elicits localized, mucosal IgA immunity in rhesus macaques correlated with delayed acquisition following a repeated low-dose rectal SIV(mac2 (Q35867976) (← links)
- Association of MHC-I genotypes with disease progression in HIV/SIV infections (Q36067291) (← links)
- Pathogenic consequences of vaginal infection with CCR5-tropic simian-human immunodeficiency virus SHIVSF162P3N. (Q36154787) (← links)
- Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studies (Q36171962) (← links)
- Host restriction factors in retroviral infection: promises in virus-host interaction (Q36548179) (← links)
- Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposure (Q36667917) (← links)
- Cutting edge: novel vaccination modality provides significant protection against mucosal infection by highly pathogenic simian immunodeficiency virus (Q36674033) (← links)
- Susceptibility to repeated, low-dose, rectal SHIVSF162P3 challenge is independent of TRIM5 genotype in rhesus macaques (Q36937885) (← links)
- Derivation and Characterization of Pathogenic Transmitted/Founder Molecular Clones from Simian Immunodeficiency Virus SIVsmE660 and SIVmac251 following Mucosal Infection (Q37252894) (← links)
- TRIM5α Resistance Escape Mutations in the Capsid Are Transferable between Simian Immunodeficiency Virus Strains. (Q37448315) (← links)
- A vaccine against CCR5 protects a subset of macaques upon intravaginal challenge with simian immunodeficiency virus SIVmac251. (Q37547093) (← links)
- Balancing Trained Immunity with Persistent Immune Activation and the Risk of Simian Immunodeficiency Virus Infection in Infant Macaques Vaccinated with Attenuated Mycobacterium tuberculosis or Mycobacterium bovis BCG Vaccine. (Q37563616) (← links)
- Potential utility of GB virus type C as a preventive vaccine for HIV-1. (Q37989574) (← links)
- Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition (Q39726192) (← links)
- Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus macaques. (Q40113278) (← links)
- Maternal HIV-1 Env Vaccination for Systemic and Breast Milk Immunity To Prevent Oral SHIV Acquisition in Infant Macaques. (Q47550072) (← links)
- Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers (Q60908099) (← links)
- Current advances in HIV vaccine preclinical studies using Macaque models (Q92019600) (← links)